These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 11709301)

  • 1. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
    Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats.
    Martinez A; Regadera J; Jimenez E; Santos I; Gargallo-Viola D
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1008-13. PubMed ID: 11257009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model.
    Chami F; Chami N; Bennis S; Trouillas J; Remmal A
    J Antimicrob Chemother; 2004 Nov; 54(5):909-14. PubMed ID: 15456732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo.
    Chami N; Bennis S; Chami F; Aboussekhra A; Remmal A
    Oral Microbiol Immunol; 2005 Apr; 20(2):106-11. PubMed ID: 15720571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacies of GW471552 and GW471558, two new azasordarin derivatives, against pneumocystosis in two immunosuppressed-rat models.
    Jimenez E; Martínez A; Aliouat el M; Caballero J; Dei-Cas E; Gargallo-Viola D
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2648-50. PubMed ID: 12121948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis.
    de Oliveira Neto AS; Souza ILA; Amorim MES; de Freitas Souza T; Rocha VN; do Couto RO; Fabri RL; de Freitas Araújo MG
    Med Mycol; 2021 May; 59(5):476-485. PubMed ID: 32823281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model.
    González GM; Robledo E; Saldívar D; González G; Bosques F; Garza E
    Med Mycol; 2007 May; 45(3):221-4. PubMed ID: 17464843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Histatin5 in a murine model of vulvovaginal candidiasis caused by Candida albicans.
    Liao H; Liu S; Wang H; Su H; Liu Z
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Preclinical Study of Galloylquinic Acid Compounds from
    Al-Madboly LA; Abd El-Salam MA; Bastos JK; El-Shorbagy SH; El-Morsi RM
    Microbiol Spectr; 2022 Oct; 10(5):e0272421. PubMed ID: 35972130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Syngonanthus nitens (Bong.) Ruhl. extract as antifungal and in treatment of vulvovaginal candidiasis.
    de Freitas Araújo MG; Pacífico M; Vilegas W; Dos Santos LC; Icely PA; Miró MS; Scarpa MV; Bauab TM; Sotomayor CE
    Med Mycol; 2013 Oct; 51(7):673-82. PubMed ID: 23758104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal activities and cytotoxicity studies of six new azasordarins.
    Herreros E; Almela MJ; Lozano S; Gomez de las Heras F; Gargallo-Viola D
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3132-9. PubMed ID: 11600368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
    de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
    J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans.
    Melkoumov A; Goupil M; Louhichi F; Raymond M; de Repentigny L; Leclair G
    J Antimicrob Chemother; 2013 Sep; 68(9):2099-105. PubMed ID: 23620465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis.
    Luna-Tapia A; Peters BM; Eberle KE; Kerns ME; Foster TP; Marrero L; Noverr MC; Fidel PL; Palmer GE
    Eukaryot Cell; 2015 Oct; 14(10):1006-16. PubMed ID: 26231054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, stability study and preclinical evaluation of a vaginal cream containing curcumin in a rat model of vulvovaginal candidiasis.
    Fernandes LS; Amorim YM; da Silva EL; Silva SC; Santos AJA; Peixoto FN; Neves Pires LM; Sakamoto RY; Horta Pinto FDC; Scarpa MVC; Araújo MGF
    Mycoses; 2018 Oct; 61(10):723-730. PubMed ID: 29517833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of Estrogen and Immunosuppressive Agents to Establish a Mouse Model of Candidiasis with Concurrent Oral and Vaginal Mucosal Infection.
    Wang L; Wang C; Mei H; Shen Y; Lv G; Zeng R; Zhan P; Li D; Liu W
    Mycopathologia; 2016 Feb; 181(1-2):29-39. PubMed ID: 26404163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model.
    Hayama K; Ishibashi H; Ishijima SA; Niimi K; Tansho S; Ono Y; Monk BC; Holmes AR; Harding DR; Cannon RD; Abe S
    FEMS Microbiol Lett; 2012 Mar; 328(2):130-7. PubMed ID: 22211961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic anti-candidal activity of tetrandrine on ketoconazole: an experimental study.
    Zhang H; Wang K; Zhang G; Ho HI; Gao A
    Planta Med; 2010 Jan; 76(1):53-61. PubMed ID: 19644794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental oral candidiasis in healthy and immunocompromised BALB/c mice].
    Karaman M; Kiray M; Bayrakal V; Bağrıyanık HA; Yılmaz O; Bahar IH
    Mikrobiyol Bul; 2011 Apr; 45(2):336-43. PubMed ID: 21644077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of sordarins in experimental models of candidiasis, aspergillosis, and pneumocystosis.
    Martinez A; Aviles P; Jimenez E; Caballero J; Gargallo-Viola D
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3389-94. PubMed ID: 11083645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.